Phytosterols

Compound Class	Plant sterols and stanols — a family of cholesterol-analogue steroids; not a single molecule
Principal Members	β-Sitosterol (dominant), campesterol, stigmasterol; saturated stanol forms (sitostanol, campestanol)
Sources	Vegetable oils, nuts, seeds, legumes; commercial material from tall oil or vegetable oil deodoriser distillate
Typical Standardisation	Total phytosterols by GC with individual sterol profile; 95% commercial grade
Established Mechanism	Competitive displacement of cholesterol from intestinal mixed micelles — reducing cholesterol absorption
Effective Dose	≥2 g/day for meaningful LDL reduction. Below ~0.8 g/day, effect is negligible
Claim Strength (Overview)	High — one of the best-evidenced non-pharmaceutical LDL-lowering interventions; authorised health claims exist in the EU
Buy from Herbuno	Natural Phytosterol 95% Powder → Beta Sitosterol 80% Powder →

Name origin: Phytosterol means, simply, plant sterol — a family of steroid alcohols structurally near-identical to cholesterol but differing in the side chain, typically by an extra methyl or ethyl group. That structural near-identity is precisely why they work: they compete with cholesterol for the same limited space in intestinal micelles. Stanols are the saturated (5α-reduced) counterparts. Traditional use: No traditional system identified phytosterols as such, though they are ubiquitous in the plant foods of every traditional diet. Their therapeutic use dates to the 1950s, when plant sterols were first shown to lower serum cholesterol, and to the 1990s commercial launch of sterol-enriched margarines. Research trajectory: Phytosterols occupy an unusual position in this index: they are one of the very few supplement-category ingredients whose principal claim is well established, mechanistically clear, dose-defined, and supported by authorised health claims in the EU. This page therefore has the pleasant task of reporting a claim that holds — and the less pleasant one of noting the dose reality that most commercial products ignore. Commercial source: Phytosterols from tall oil or vegetable oil deodoriser distillate; also β-sitosterol-enriched grades.

---

Evidence for Phytosterols Applications

The mechanism is established, specific, and not in serious dispute. Phytosterols are structurally and functionally similar to cholesterol but cannot be utilised by humans; they compete with cholesterol for incorporation into the mixed micelles that form in the intestinal lumen, thereby inhibiting intestinal cholesterol absorption and lowering blood cholesterol. Consumption of 1.5–1.8 g/day of phytosterols has been shown to reduce cholesterol absorption by as much as 36%, and intake of at least 0.8 g daily can lower blood LDL-cholesterol (Ottestad 2019). That same randomized placebo-controlled double-blind crossover study in 32 healthy adults found that phytosterol supplementation at 1.5 g/day lowered LDL cholesterol by 10.2%. Claim strength: High.

The dose threshold is the single most actionable fact for a formulator, and it is where most commercial products fail. A systematic review of randomized clinical trials on phytosterols and metabolic syndrome components reported findings consistent with a 2024 umbrella review, which found that phytosterol consumption at doses of ≥2 g/day for ≥8 weeks significantly decreased LDL-C, total cholesterol, and triglyceride levels, with the greatest effects in persons with hypercholesterolemia specifically (Diabetol Metab Syndr 2025). A capsule delivering 200 mg of phytosterols is delivering a tenth of the effective dose, and this is extremely common in the market. Claim strength: High.

The effect size is worth stating precisely rather than inflating. Pooled meta-analytic work has found phytosterols lower LDL-C by around 0.5–0.6 mmol/L on average, corresponding to roughly a 5–15% reduction depending on dose and baseline, with the response plateauing above roughly 2–3 g/day — more is not proportionally better. This is a real, reproducible, clinically meaningful effect, and it is also considerably smaller than a statin. Phytosterols are a dietary adjunct, not a substitute for pharmacotherapy in anyone who needs it. Claim strength: High.

Delivery matters more than the raw sterol number, and this is where a 95% powder needs honest handling. Phytosterols are poorly soluble in both water and fat in their free crystalline form, and their efficacy depends on being solubilised into the intestinal micellar phase. This is why the effective commercial products historically were sterol esters in fat-containing food matrices (margarines, yoghurts, milk) rather than dry crystalline sterol in a capsule. A free-sterol powder in a hard capsule taken without food is a poor delivery vehicle, and formulators should design around this rather than around the assay figure. Claim strength: High (established formulation science).

Two caveats deserve statement because they are routinely omitted. First, phytosterols modestly reduce absorption of fat-soluble carotenoids — β-carotene in particular — and regular users are generally advised to maintain adequate fruit and vegetable intake. Second, and more seriously: sitosterolemia (phytosterolemia) is a rare recessive disorder in which phytosterol absorption is grossly elevated and plasma phytosterols can be several thousand percent above normal, associated with premature atherosclerosis. Phytosterol supplementation is contraindicated in this population. The broader question of whether modest plasma phytosterol elevation in normal individuals carries any atherogenic risk has been debated; a meta-analysis of 41 RCTs found average intake of 1.6 g/day raised plasma sitosterol and campesterol by roughly 31% and 37% respectively, and no association was found between plasma phytosterol concentration and coronary heart disease. Claim strength: Moderate.

---

Dosage & Formulator Specification

Herbuno carries Natural Phytosterol 95% powder and Beta Sitosterol 80% powder. The distinct Beta-Sitosterol page in this index covers the dominant single sterol; this page covers the mixture. Formulators should note that both are free crystalline sterols and will require a delivery strategy — esterification, solubilisation, or a fat-containing matrix — to reproduce the trial-literature efficacy.

The dose is not negotiable and it is the thing most products get wrong: ≥2 g/day of phytosterols, sustained for at least eight weeks, is the intake at which the LDL-lowering effect is reliably observed; 1.5–1.8 g/day produces measurable but smaller effects, and below roughly 0.8 g/day the effect approaches negligible. A 2 g daily dose of a 95% powder means roughly 2.1 g of material per day — this is a food-format or multi-capsule proposition, not a single small capsule, and a formulator who cannot deliver that quantity should reconsider the claim rather than the dose. Intake should be split across meals containing fat.

Analytical verification should specify total phytosterols by gas chromatography with the individual sterol profile — β-sitosterol, campesterol, stigmasterol, and the corresponding stanols quantified separately — since the ratio varies with source material and both the EU health claim wording and the trial literature are framed around defined compositions. Whether the material is free sterol or sterol ester must be documented, as this is determinative of delivery. Source (tall oil versus vegetable oil deodoriser distillate) should be stated, along with residual solvent and, for tall oil derived material, appropriate purity documentation.

Phytosterols have a long history of dietary consumption and an extensive safety record at intakes to 3 g/day; gastrointestinal effects are the most commonly reported. Three cautions. Sitosterolemia is an absolute contraindication — a rare recessive disorder in which phytosterol absorption is grossly elevated and associated with premature atherosclerosis. Phytosterols modestly reduce absorption of fat-soluble carotenoids, particularly β-carotene, and users should be advised to maintain fruit and vegetable intake. Phytosterols are not recommended for children or during pregnancy and breastfeeding, where cholesterol is required for normal development, and this restriction appears in the EU authorised-claim conditions rather than being a precautionary invention.

---

Frequently Asked Questions — Phytosterols

What dose of phytosterols actually works?
At least 2 g/day, sustained for eight weeks or more — that is the intake at which the LDL-lowering effect is reliably observed. Below roughly 0.8 g/day the effect approaches negligible. A capsule delivering 200 mg is delivering a tenth of the effective dose, and that is very common in the market.

How much does it lower LDL?
Around 5-15%, or roughly 0.5-0.6 mmol/L in pooled meta-analyses, with the response plateauing above about 2-3 g/day. Real, reproducible, clinically meaningful — and considerably smaller than a statin. Phytosterols are a dietary adjunct, not a substitute for pharmacotherapy in anyone who needs it.

Does a crystalline phytosterol capsule work as well as a fortified spread?
Probably not, and this is under-appreciated. Free crystalline phytosterols are poorly soluble in both water and fat, and efficacy depends on solubilisation into the intestinal micellar phase. The effective commercial products historically were sterol esters in fat-containing matrices. A dry powder in a capsule taken without food is a poor delivery vehicle.

Who should not take phytosterols?
Anyone with sitosterolemia — a rare recessive disorder of grossly elevated phytosterol absorption associated with premature atherosclerosis — for whom they are contraindicated. They are also not recommended for children or during pregnancy and breastfeeding, where cholesterol is needed for normal development. That restriction appears in the EU authorised-claim conditions.

Related compounds: Beta-Sitosterol, Policosanol, Saw Palmetto Fatty Acids, Coenzyme Q10

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery